![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EUROFINS STRENGTHENS POSITION IN GLOBAL CLINICAL TRIALS MARKET WITH ACQUISITION OF FOCUS BIO-INOVA
EUROFINS STRENGTHENS POSITION IN GLOBAL CLINICAL TRIALS MARKET WITH ACQUISITION OF FOCUS BIO-INOVA
June 16, 2006
Eurofins Scientific strengthens its position in the global clinical trials market, and expands its testing services portfolio to the pharmaceutical and biotechnology industries with the acquisition of Focus Bio-Inova (FBI).
Euronext
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct